McKesson Corporation's Revenue by Segment
In fiscal year 2025, McKesson Corporation's revenue by segment (products & services) are as follows:
- International Segment: $14.72 B
- Medical-Surgical Solutions Segment: $11.39 B
- Prescription Technology Solutions: $5.22 B
- U.S. Pharmaceutical Segment: $327.72 B
Learn more about McKesson Corporation’s Revenue by Geography
Check out competitors to McKesson Corporation in a side-by-side comparison.
Explore additional financial metrics for McKesson Corporation.
| International Segment | 20598000000 |
|---|---|
| Medical-Surgical Solutions Segment | 11110000000 |
| Prescription Technology Solutions | 4387000000 |
| U.S. Pharmaceutical Segment | 240616000000 |
| International Segment | 14130000000 |
|---|---|
| Medical-Surgical Solutions Segment | 11313000000 |
| Prescription Technology Solutions | 4769000000 |
| U.S. Pharmaceutical Segment | 278739000000 |
| International Segment | 14721000000 |
|---|---|
| Medical-Surgical Solutions Segment | 11386000000 |
| Prescription Technology Solutions | 5216000000 |
| U.S. Pharmaceutical Segment | 327717000000 |
The above chart shows McKesson Corporation's revenue percentage share by segment (products and services).
In fiscal year 2023, McKesson Corporation's revenue by segment is as follows:
- International Segment generated $20.60 B in revenue, representing 7.44% of its total revenue.
- Medical-Surgical Solutions Segment generated $11.11 B in revenue, representing 4.02% of its total revenue.
- Prescription Technology Solutions generated $4.39 B in revenue, representing 1.59% of its total revenue.
- U.S. Pharmaceutical Segment generated $240.62 B in revenue, representing 86.96% of its total revenue.
The biggest segment for McKesson Corporation is the U.S. Pharmaceutical Segment, which represents 86.96% of its total revenue.
The smallest segment for McKesson Corporation is the Prescription Technology Solutions, which represents 1.59% of its total revenue.
The above chart shows McKesson Corporation's revenue percentage share by segment (products and services).
In fiscal year 2024, McKesson Corporation's revenue by segment is as follows:
- International Segment generated $14.13 B in revenue, representing 4.57% of its total revenue.
- Medical-Surgical Solutions Segment generated $11.31 B in revenue, representing 3.66% of its total revenue.
- Prescription Technology Solutions generated $4.77 B in revenue, representing 1.54% of its total revenue.
- U.S. Pharmaceutical Segment generated $278.74 B in revenue, representing 90.22% of its total revenue.
The biggest segment for McKesson Corporation is the U.S. Pharmaceutical Segment, which represents 90.22% of its total revenue.
The smallest segment for McKesson Corporation is the Prescription Technology Solutions, which represents 1.54% of its total revenue.
The above chart shows McKesson Corporation's revenue percentage share by segment (products and services).
In fiscal year 2025, McKesson Corporation's revenue by segment is as follows:
- International Segment generated $14.72 B in revenue, representing 4.1% of its total revenue.
- Medical-Surgical Solutions Segment generated $11.39 B in revenue, representing 3.17% of its total revenue.
- Prescription Technology Solutions generated $5.22 B in revenue, representing 1.45% of its total revenue.
- U.S. Pharmaceutical Segment generated $327.72 B in revenue, representing 91.28% of its total revenue.
The biggest segment for McKesson Corporation is the U.S. Pharmaceutical Segment, which represents 91.28% of its total revenue.
The smallest segment for McKesson Corporation is the Prescription Technology Solutions, which represents 1.45% of its total revenue.
Summary Table
| Products & Services (Percent Share) | 2023 | 2024 | 2025 |
|---|---|---|---|
| International Segment | 7.44% | 4.57% | 4.1% |
| Medical-Surgical Solutions Segment | 4.02% | 3.66% | 3.17% |
| Prescription Technology Solutions | 1.59% | 1.54% | 1.45% |
| U.S. Pharmaceutical Segment | 86.96% | 90.22% | 91.28% |
| Total Revenue | 100% | 100% | 100% |
The above chart shows the revenue trend of different segments of McKesson Corporation.
In fiscal year 2025, the U.S. Pharmaceutical Segment generated the most revenue ($327.72 B), and the Prescription Technology Solutions generated the least revenue ($5.22 B).
The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.
Summary Table
| Products & Services | 2023 | 2024 | 2025 |
|---|---|---|---|
| International Segment | $20.60 B - |
$14.13 B
31.40%
|
$14.72 B
4.18%
|
| Medical-Surgical Solutions Segment | $11.11 B - |
$11.31 B
1.83%
|
$11.39 B
0.65%
|
| Prescription Technology Solutions | $4.39 B - |
$4.77 B
8.71%
|
$5.22 B
9.37%
|
| U.S. Pharmaceutical Segment | $240.62 B - |
$278.74 B
15.84%
|
$327.72 B
17.57%
|
| Total Revenue | $276.71 B - |
$308.95 B
11.65%
|
$359.04 B
16.21%
|
Related
-
Agilent Technologies Revenue by Segment
-
Eli Lilly and Company Revenue by Segment
-
Stryker Corporation Revenue by Segment
-
Johnson & Johnson Revenue by Segment
-
AbbVie Revenue by Segment
-
Merck & Co. Revenue by Segment
-
Thermo Fisher Scientific Revenue by Segment
-
Abbott Laboratories Revenue by Segment
-
Danaher Corporation Revenue by Segment
-
Amgen Revenue by Segment
